This company listing is no longer active
Capitol Health Past Earnings Performance
Past criteria checks 0/6
Capitol Health's earnings have been declining at an average annual rate of -52.1%, while the Healthcare industry saw earnings declining at 3.3% annually. Revenues have been growing at an average rate of 9.4% per year.
Key information
-52.1%
Earnings growth rate
-56.2%
EPS growth rate
| Healthcare Industry Growth | 2.4% |
| Revenue growth rate | 9.4% |
| Return on equity | -13.3% |
| Net Margin | -6.3% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Calculating The Fair Value Of Capitol Health Limited (ASX:CAJ)
Jun 17
Capitol Health Limited's (ASX:CAJ) Popularity With Investors Is Clear
Jan 15Capitol Health (ASX:CAJ) Takes On Some Risk With Its Use Of Debt
Dec 15Is Capitol Health Limited (ASX:CAJ) Worth AU$0.3 Based On Its Intrinsic Value?
Oct 22Capitol Health (ASX:CAJ) Seems To Use Debt Rather Sparingly
May 28Should You Investigate Capitol Health Limited (ASX:CAJ) At AU$0.37?
Apr 16Capitol Health Limited's (ASX:CAJ) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Mar 05Have Insiders Been Selling Capitol Health Limited (ASX:CAJ) Shares This Year?
Feb 14Did You Miss Capitol Health's (ASX:CAJ) 20% Share Price Gain?
Jan 19
Is Capitol Health Limited's (ASX:CAJ) Shareholder Ownership Skewed Towards Insiders?
Dec 22Capitol Health Limited's (ASX:CAJ) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Dec 01Here's Why We Don't Think Capitol Health's (ASX:CAJ) Statutory Earnings Reflect Its Underlying Earnings Potential
Aug 17Is Now An Opportune Moment To Examine Capitol Health Limited (ASX:CAJ)?
Jul 25Is Capitol Health Limited's (ASX:CAJ) Latest Stock Performance A Reflection Of Its Financial Health?
Jul 04Revenue & Expenses Breakdown
How Capitol Health makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 235 | -15 | 7 | 0 |
| 31 Mar 24 | 232 | -5 | 7 | 0 |
| 31 Dec 23 | 229 | 6 | 7 | 0 |
| 30 Sep 23 | 219 | -3 | 7 | 0 |
| 30 Jun 23 | 210 | -12 | 7 | 0 |
| 31 Mar 23 | 198 | -12 | 6 | 0 |
| 31 Dec 22 | 187 | -12 | 5 | 0 |
| 30 Sep 22 | 186 | -1 | 5 | 0 |
| 30 Jun 22 | 184 | 11 | 5 | 0 |
| 31 Mar 22 | 186 | 12 | 5 | 0 |
| 31 Dec 21 | 188 | 14 | 5 | 0 |
| 30 Sep 21 | 183 | 13 | 5 | 0 |
| 30 Jun 21 | 178 | 12 | 5 | 0 |
| 31 Mar 21 | 168 | 8 | 5 | 0 |
| 31 Dec 20 | 159 | 4 | 4 | 0 |
| 30 Sep 20 | 156 | 3 | 4 | 0 |
| 30 Jun 20 | 154 | 1 | 4 | 0 |
| 31 Mar 20 | 156 | 8 | 6 | 0 |
| 31 Dec 19 | 157 | 15 | 8 | 0 |
| 30 Sep 19 | 153 | 20 | 9 | 0 |
| 30 Jun 19 | 149 | 24 | 11 | 0 |
| 31 Dec 18 | 137 | -2 | 8 | 0 |
| 30 Sep 18 | 128 | -6 | 8 | 0 |
| 30 Jun 18 | 119 | -11 | 8 | 0 |
| 31 Dec 17 | 110 | 2 | 12 | 0 |
| 30 Sep 17 | 108 | 2 | 12 | 0 |
| 30 Jun 17 | 107 | 2 | 12 | 0 |
| 31 Dec 16 | 80 | 1 | 9 | 0 |
| 30 Sep 16 | 92 | 2 | 10 | 0 |
| 30 Jun 16 | 104 | 2 | 11 | 0 |
| 31 Mar 16 | 148 | -2 | 17 | 0 |
| 31 Dec 15 | 139 | 1 | 16 | 0 |
| 30 Sep 15 | 125 | 3 | 14 | 0 |
| 30 Jun 15 | 110 | 4 | 13 | 0 |
| 31 Mar 15 | 103 | 6 | 12 | 0 |
| 31 Dec 14 | 95 | 9 | 12 | 0 |
| 30 Sep 14 | 92 | 8 | 11 | 0 |
| 30 Jun 14 | 90 | 7 | 11 | 0 |
| 31 Mar 14 | 83 | 6 | 10 | 0 |
| 31 Dec 13 | 77 | 5 | 9 | 0 |
Quality Earnings: CAJ is currently unprofitable.
Growing Profit Margin: CAJ is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CAJ is unprofitable, and losses have increased over the past 5 years at a rate of 52.1% per year.
Accelerating Growth: Unable to compare CAJ's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: CAJ is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-25.4%).
Return on Equity
High ROE: CAJ has a negative Return on Equity (-13.34%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/11 19:12 |
| End of Day Share Price | 2024/12/11 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Capitol Health Limited is covered by 9 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Russell Wright | Barclay Pearce Capital Pty Limited |
| Andrew Hodge | Credit Suisse |
| Daniel Downes | Goldman Sachs |